河北治癫痫的医院哪里有滨州怎么治疗羊羔疯,淄博癫痫怎样恢复的快,河北中医怎样治疗儿童羊癫疯,德州治疗癫痫哪个医院效果比较好,山东有羊羔疯病专科医院吗,全国癫痫病医院治癫痫哪个好,安徽癫痫病的中医治疗方法

The College Football Playoff semifinal at the Rose Bowl is moving to AT&T Stadium in Arlington, Texas.Bill Hancock, executive director of the College Football Playoff, made the announcement in a statement Saturday night on the eve of the release of the final playoff rankings.The College Football Playoff and Rose Bowl "mutually agreed" to move the game because of the growing number of coronavirus cases in Southern California."We are pleased that parents and loved ones will now be able to see their students play in the game," Hancock said.The move came after several coaches expressed their dismay about possibly traveling to the Rose Bowl to play in a game where players' families wouldn't be allowed.Los Angeles County is under a stay-at-home order that took effect earlier this month. Pasadena, home to the Rose Bowl, has its own public health department but has mostly followed the county's practices during the pandemic.A source told The Associated Press that the Rose Bowl sought an exemption from the state of California to allow families to attend but was denied twice.Hancock said the game will still be played in the mid-afternoon on New Year's Day."We are very grateful to Rose Bowl officials and the city of Pasadena," Hancock said. "They have worked hard to listen to the concerns of the CFP, the teams that might have played there, and their state and government officials. The Tournament of Roses has acted in the best interest of the people who live in Southern California, and we're grateful to Cotton Bowl and AT&T Stadium officials for their ability to make this late switch possible." 1624

The criminal justice system across the United States has a backlog of cases because of the pandemic. In the meantime, the victims' families wait anxiously for justice.Arnulfo Ochoa cannot control his tears as he looks at a picture of his late daughter Marlen Ochoa-Lopez, who would have celebrated her 21st birthday this month.The suspects, Clarissa Figueroa, and her daughter, Desiree, lured the victim to a house with the promise of free baby clothes. They then allegedly strangled Marlen, before taking the baby from her womb.The Figueroas face first-degree murder charges.Ochoa says he is frustrated because COVID-19 has forced the courts to reschedule the hearings over and over.The National District Attorneys Association says there are backlogs of criminal cases in every state, and daily court dockets have fewer cases because of the social-distancing restrictions. In many cases, trials and hearings are done remotely. 935

The FDA has ended an emergency use authorization (EUA) order for hydroxychloroquine, saying that the agency has determined that drug is "unlikely to be effective in treating COVID-19."In the announcement, the agency said that the benefits of hydroxychloroquine and a related drug, chloroquine phosphate, "no longer outweigh the known and potential risks for the authorized use."The FDA issued the EUA for the drug in March. In April, the FDA warned that the drug should only be used in hospital settings due to the severe side effects some experienced while taking the drug.Shortly after the coronavirus arrived in the United States, President Donald Trump touted the drug as a potential treatment for the disease. He encouraged those sickened with the virus to take the drugs, saying, "what do you have to lose?"Trump said he took the drug for a few weeks in May as several White House staffers contracted the virus. In an open letter, White House physician Sean Conley said he prescribed the drugs after determining that the "potential benefit from treatment outweighed the relative risks."Earlier this month, a study showed that the drug was likely not effective in treating COVID-19. That study was published just days after a separate study — which determined that people who took the drugs died at a higher rate than those who did not take the drugs — was retracted by three of its authors. 1404

The delayed Tokyo Olympics could not be held next year if conditions surrounding the coronavirus pandemic continue as they are, the president of the organizing committee said Wednesday.In an interview with Japanese broadcaster NHK, Yoshiro Mori said he was hopeful the situation would improve and suggested a vaccine was the key.“If this kind of situation (with COVID-19) continues, is it possible to hold the games?” Mori was asked by NHK.“If current situation continues, we couldn’t,” Mori replied, speaking in Japanese.The Tokyo Olympics are scheduled to open on July 23, 2021 — a year from Thursday. A small, 15-minute ceremony without fans is scheduled for Thursday at the new national stadium to mark the date.The International Olympic Committee and Japanese organizers have repeatedly expressed confidence the games will take place, though they have offered few details on how they can happen in the middle of a pandemic.The IOC and organizers have also said the Olympics will not be postponed again and would be canceled.“It would be too much for us to answer each of these hypothetical questions,” Mori said. “I don’t think this situation will last for another year.”Researchers have said a vaccine could be six-to-nine months away, which Mori said was the key. Some, however, question if young athletes should be a priority, and if all would agree to be vaccinated.“Whether the Olympics can be done or not is about whether humanity can beat the coronavirus,” Mori said. “Specifically, to develop a vaccine or drug is the first point.”Organizers and the IOC say they want to simplify the games to help reduce the soaring costs. But officials cannot say now if fans will be permitted next year, or if athletes will face quarantines. They say few details will be available until the fall.Plans call for the full contingent of 11,000 Olympic athletes and 4,400 Paralympic athletes to be competing at 42 venues.About 1,000 deaths in Japan have been attributed to the coronavirus. Tokyo has seen a rising number of daily cases in the last few weeks, which reached a high of almost 300 last week.But the numbers are relatively modest for a metropolitan area of 14 million.___More AP sports: https://apnews.com/apf-sports and https://twitter.com/AP_Sports 2265

The current spike in COVID-19 cases is stressing the testing system across the country.As the virus spreads at unprecedented rates, more Americans are seeking COVID-19 tests. But in recent days, companies that make the tests and the supplies needed for them are struggling to keep up with demand."Those companies were operating on an allocation basis, and that just means that basically everything they make is going out the door," said Kelly Wroblewski, the Director of Infectious Disease Programs at the Association of Public Health Laboratories. "There is no reserve, so there's an increased demand in a lab for testing. There's no more reagent to be had, so to meet that demand, that lab has to use a different manufacturer's test."Wroblewski adds that along with issues in getting supplies, officials are also short on human resources — there is only so much lab capacity and only so many trained people to conduct the tests.The American Clinical Laboratory Association says the surge in demand for testing means some labs could reach or exceed their current testing capacities soon — meaning it could take longer for patients to get PCR test results back.Wroblewski says that it can take currently take anywhere from 24 hours to a week to get PCR test results back.With antigen tests, patients can get results back in less than 30 minutes. There is currently enough of a supply for antigen tests, but not all facilities offer them.Both lab groups stress that COVID-19 testing is important, but patients should be strategic."There's been a lot of emphasis put on testing, but testing is only one piece of the puzzle," Wroblewski said. "It gives you some information, and if you're not going to do anything with that information — whether it be targeted closures. whether it be staying home and isolating — we're not going to stop the spread of disease."As far as getting more tests, it's going to take a while. Wroblewski says it could take up to six months or more to increase production capacity significantly. Labs don't expect to see a ramp-up in supplies until early 2021. 2090